Journal ArticleDOI
Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism
Reads0
Chats0
TLDR
The results demonstrate the saturable transfer of L‐KYN across the blood–brain barrier and suggest that circulating L‐ KYN, 3‐HKYN, and ANA may each contribute significantly to respective cerebral pools under normal conditions.Abstract:
To evaluate the potential contribution of circulating kynurenines to brain kynurenine pools, the rates of cerebral uptake and mechanisms of blood-brain barrier transport were determined for several kynurenine metabolites of tryptophan, including L-kynurenine (L-KYN), 3-hydroxykynurenine (3-HKYN), 3-hydroxyanthranilic acid (3-HANA), anthranilic acid (ANA), kynurenic acid (KYNA), and quinolinic acid (QUIN), in pentobarbital-anesthetized rats using an in situ brain perfusion technique. L-KYN was found to be taken up into brain at a significant rate [permeability-surface area product (PA) = 2-3 x 10(-3) ml/s/g] by the large neutral amino acid carrier (L-system) of the blood-brain barrier. Best-fit estimates of the Vmax and Km of saturable L-KYN transfer equalled 4.5 x 10(-4) mumol/s/g and 0.16 mumol/ml, respectively. The same carrier may also mediate the brain uptake of 3-HKYN as D,L-3-HKYN competitively inhibited the brain transfer of the large neutral amino acid L-leucine. For the other metabolites, uptake appeared mediated by passive diffusion. This occurred at a significant rate for ANA (PA, 0.7-1.6 x 10(-3) ml/s/g), and at far lower rates (PA, 2-7 x 10(-5) ml/s/g) for 3-HANA, KYNA, and QUIN. Transfer for KYNA, 3-HANA, and ANA also appeared to be limited by plasma protein binding. The results demonstrate the saturable transfer of L-KYN across the blood-brain barrier and suggest that circulating L-KYN, 3-HKYN, and ANA may each contribute significantly to respective cerebral pools. In contrast, QUIN, KYNA, and 3-HANA cross the blood-brain barrier poorly, and therefore are not expected to contribute significantly to brain pools under normal conditions.read more
Citations
More filters
Journal ArticleDOI
Serum kynurenine metabolites might not be associated with risk factors of treatment-resistant schizophrenia.
Junchao Huang,Ping Zhang,Yanfang Zhou,Jinghui Tong,Yimin Cui,Shuping Tan,Zhiren Wang,Fude Yang,Peter Kochunov,Baopeng Tian,Li Tian,L. Elliot Hong,Yunlong Tan +12 more
TL;DR: In this paper, the authors measured TRP metabolites in 54 patients with TRS and compared them to 49 age-and sex-matched patients who responded to antipsychotics (NTRS), and 62 healthy controls using liquid chromatography-tandem mass spectrometry.
Journal ArticleDOI
Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder
K. M. Skorobogatov,V. Autier,Marianne Foiselle,Jean Romain Richard,Wahid Boukouaci,Ching-Lien Wu,S. Raynal,C. Carbonne,Kris Laukens,Pieter Meysman,Violette Coppens,Philippe Le Corvoisier,Caroline Barau,Livia De Picker,Manuel Morrens,Ryad Tamouza,Marion Leboyer +16 more
TL;DR: In this article , the impact of serum kynurenine metabolite levels on diagnosis, clinical state, symptom severity and clinical course in a large French transdiagnostic cohort of schizophrenia and bipolar disorder patients was investigated.
Posted ContentDOI
Serum Metabolites Associated with Brain Amyloid Beta Deposition, Cognitive Dysfunction, and Alzheimer’s Disease Progression
Kwangsik Nho,Alexandra Kueider-Paisley,Matthias Arnold,Siamak MahmoudianDehkordi,Shannon L. Risacher,Gregory Louie,Colette Blach,Rebecca Baillie,Xianlin Han,Gabi Kastenmueller,P. M. Doraiswamy,Rima Kaddurah-Daouk,Andrew J. Saykin +12 more
TL;DR: Perturbations in PC and acylcarnitine metabolism may play a role in features intrinsic to AD including amyloid-β deposition and cognitive performance.
Journal ArticleDOI
Fighting the Consequences of the COVID-19 Pandemic: Mindfulness, Exercise, and Nutrition Practices to Reduce Eating Disorders and Promote Sustainability
Sara Baldassano,Anna Paraskevi Alioto,Alessandra Amato,Carlo Rossi,Giulia Messina,Maria R Bruno,Roberta Stallone,Patrizia Proia +7 more
TL;DR: In this paper , the benefits associated with the mindfulness-exercise-nutrition (MEN) technique are discussed and discussed from a nutritional point of view, focusing on the nutritional effect of a plant-based diet such as the Mediterranean diet (MD) which has a high tryptophan content which can increase serotonin (the “feel good” hormone) levels.
Journal ArticleDOI
Left DLPFC activity is associated with plasma kynurenine levels and can predict treatment response to escitalopram in major depressive disorder
Toshiharu Kamishikiryo,Go Okada,Eri Itai,Yoshikazu Masuda,Satoshi Yokoyama,Masahiro Takamura,Manabu Fuchikami,Atsuo Yoshino,Kazuaki Mawatari,Shusuke Numata,Akira Takahashi,Tetsuro Ohmori,Yasumasa Okamoto +12 more
TL;DR:
References
More filters
Journal ArticleDOI
Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain
TL;DR: Intracerebral injection of the neuroexcitatory tryptophan metabolite, quinolinic acid, has behavioral, neurochemical and neuropathological consequences reminiscent of those of exogenous excitotoxins, such as kainic and ibotenic acids.
Journal ArticleDOI
Distinct mediating systems for the transport of neutral amino acids by the ehrlich cell
Journal ArticleDOI
Amino acid assignment to one of three blood-brain barrier amino acid carriers
William H. Oldendorf,John Szabo +1 more
TL;DR: Affinity for a basic amino acid carrier system was demonstrated for arginine, ornithine, and lysine and a third, low-capacity independent carrier system transporting aspartic and glutamic acids was demonstrated.
Journal ArticleDOI
An in situ brain perfusion technique to study cerebrovascular transport in the rat
TL;DR: The in situ brain perfusion technique is a sensitive new method to study cerebrovascular transfer in the rat and permits absolute control of perfusate composition.